Last update 08 May 2025

EBV Protein x 4-1BB

Basic Info

Related Targets
EBV Protein4-1BB

Related

1
Drugs associated with EBV Protein x 4-1BB
CD137L-DC-EBV-VAX(National University Hospital, Singapore)
Target
4-1BB x EBV Protein
Mechanism
4-1BB agonists [+1]
Active Org.-
Originator Org.
National University Hospital (S) Pte Ltd.
Active Indication-
Inactive Indication
Advanced Nasopharyngeal Carcinoma
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with EBV Protein x 4-1BB
NCT03282617
/ Unknown statusPhase 1IIT
Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal Carcinoma
100 Clinical Results associated with EBV Protein x 4-1BB
Login to view more data
100 Translational Medicine associated with EBV Protein x 4-1BB
Login to view more data
0 Patents (Medical) associated with EBV Protein x 4-1BB
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free